|
|
Blood, 1 August 2005, Vol. 106, No. 3, pp. 879-885.
Prepublished online as a Blood First Edition Paper on April 14, 2005; DOI 10.1182/blood-2005-02-0456.
Previous Article | Next Article 
Submitted February 2, 2005
Accepted April 5, 2005
IL-6 blocks a discrete early step in lymphopoiesis
Kazuhiko Maeda, Yoshihiro Baba, Yoshinori Nagai, Kozo Miyazaki, Alexander Malykhin, Koji Nakamura, Paul W Kincade, Nobuo Sakaguchi, and K M Coggeshall*
Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA
Department of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
Immunobiology and Cancer Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
* Corresponding author; email: coggeshallm{at}omrf.ouhsc.edu.
Animals lacking Src homology 2 domain-containing inositol 5-phosphatase (SHIP) display a reduction in lymphopoiesis and a corresponding enhancement of myelopoiesis. These effects are mediated at least in part by elevated IL-6. Here, we show the lymphopoiesis block in SHIP-/- mice is due to suppression of the lymphoid lineage choice by uncommitted progenitors. The suppression can be reproduced in vitro with recombinant IL-6, and IL-6 acts directly on hematopoietic progenitors. The block is partially overcome in SHIP-/-IL-6-/- double-deficient animals. IL-6 does not suppress but actually enhances proliferation of lymphoid-committed progenitors, indicating the IL-6 target cells are hematopoietic stem cells or multipotent progenitors. The findings suggest a mechanism for the lymphopenia that accompanies pro-inflammatory diseases.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Maeda, A. Malykhin, B. N. Teague-Weber, X.-H. Sun, A. D. Farris, and K. M. Coggeshall
Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals
Blood,
May 7, 2009;
113(19):
4534 - 4540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Esplin, R. S. Welner, Q. Zhang, L. A. Borghesi, and P. W. Kincade
A differentiation pathway for B1 cells in adult bone marrow
PNAS,
April 7, 2009;
106(14):
5773 - 5778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. de Paiva, A. Nobrega, G. O. De Melo, E. A. Hayashi, V. Carvalho, P. M. Rodrigues e Silva, M. Bellio, G. P. Teixeira, V. Rumjanek, S. S. Costa, et al.
Selective blockade of lymphopoiesis induced by kalanchosine dimalate: inhibition of IL-7-dependent proliferation
J. Leukoc. Biol.,
April 1, 2008;
83(4):
1038 - 1048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Minami, I. Tsuboi, T. Harada, T. Fukumoto, M. Hiramoto, M. Koshinaga, Y. Hirabayashi, J. Kanno, T. Inoue, and S. Aizawa
Inflammatory Biomarker, Neopterin, Suppresses B Lymphopoiesis for Possible Facilitation of Granulocyte Responses, Which Is Severely Altered in Age-Related Stromal-Cell-Impaired Mice, SCI/SAM
Experimental Biology and Medicine,
January 1, 2007;
232(1):
134 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|